FindTrial
Sign In

Development and Validation of Interpretable Prediction Models for Successful Weaning and Bleeding Risk in Pediatric VA-ECMO Patients: A Multicenter Prospective Cohort Study in China

Research on Key technology of Cardiopulmonary Support for Neonatal/Children’s Critical Care Extracorporeal Life Support System

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109948
Enrollment
Unknown
Registered
2025-09-28
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart disease in neonatal/children supported by VA-ECMO

Interventions

Neonatal/Children patients with VA-ECMO support:None

Sponsors

The First Medical Center of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Patients with refractory cardiogenic shock, malignant arrhythmias, heart failure, etc., due to heart disease; 2. Supported with VA-ECMO; 3. Age <= 18 years; 4. Willing to provide informed consent.

Exclusion criteria

Exclusion criteria: 1. VA-ECMO duration < 24 hours; 2. VA-ECMO administered for other reasons; 3. Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Bleeding complications during VA-ECMO support;successful weaning from VA-ECMO;—

Secondary

MeasureTime frame
acute kidney injury (AKI) complications during VA-ECMO support;other complications during VA-ECMO support;Death of Pediatric VA-ECMO Patients;—

Countries

China

Contacts

Public ContactRan Zhang

The First Medical Center of Chinese PLA General Hospital

zhangran@plagh.org+86 189 0334 3763

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026